Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury

Journal of Neuroscience Research

Volumn 58, Issue 4, 1999, Pages 492-504

  McGavern, Dorian B ^a   Murray, Paul D ^a   Rodriguez, Moses ^a  

^a MAYO CLINIC   (United States)

Author keywords

Morphology; Multiple sclerosis; Myelin diseases; Neuropathology; Theiler's virus

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DEMYELINATION; HISTOPATHOLOGY; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NERVE FIBER DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REMYELINIZATION; SPINAL CORD ATROPHY; SPINAL CORD INFECTION; SPINAL CORD INJURY; TISSUE CULTURE;

ANIMALS; ATROPHY; AXONS; BETA 2-MICROGLOBULIN; CELL COUNT; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASES; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MYELIN SHEATH; NEURONS; POLIOMYELITIS; SPINAL CORD; THEILOVIRUS;

EID: 0033571378     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P     Document Type: Article

References (45)

1. Anonymous. 1998. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 352:1498-1504.
2. Asakura K, Miller DJ, Pogulis RJ, Pease LR, Rodriguez M. 1995. Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes. Mol Brain Res 34:283-293.
3. Blight AR, Decrescito V. 1986. Morphometric analysis of experimental spinal cord injury in the cat: the relation of injury intensity to survival of myelinated axons. Neuroscience 19:321-341.
4. Dal Canto MC, Lipton HL. 1977. Multiple sclerosis. Animal model: Theiler's virus infection in mice. Am J Pathol 88:497-500.
5. Dal Canto MC, Lipton HL. 1979. Recurrent demyelination in chronic central nervous system infection produced by Theiler's murine encephalomyelitis virus. J Neurol Sci 42:391-405.
6. Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, McDonald WI, Miller DH. 1995. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 118:1583-1592.
7. 1H magnetic resonance spectroscopy of chronic-cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatr 63:736-742.
8. Fehlings MG, Tator CH. 1995. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol 132:220-228.
9. Ferguson B, Matyszak MK, Esiri MM, Perry VH. 1997. Axonal damage in acute multiple sclerosis lesions. Brain 120:393-399.
10. 2-microglobulin-deficient mice. J Virol 67:589-592.
11. Filippi M, Campi A, Colombo B, Pereira C, Martinelli V, Baratti C, Comi G. 1996. A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 243:502-505.
12. Fu L, Matthews PM, Stefano N, Worsley KJ, Narayanan S, Francis G, Antel JP, Wolfson C, Arnold DL. 1998. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121:103-113.
13. Griffiths IR, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmerman HM, McCulloch M, Nadon N, Nave K. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
14. Iizuka H, Yamamoto T, Iwasaki Y, Konno H, Kadoya S. 1986. Experimental spinal cord injury: quantitation of axonal damage by automated image analysis. J Neurosurg 64:304-308.
15. Iwasaki Y, Iizuka H, Yamamoto T, Konno H, Kadoya S. 1985. Alleviation of axonal damage in acute spinal cord injury by a protease inhibitor: automated morphometric analysis of drug-effects. Brain Res 347:124-126.
16. Kidd D, Thorpe JW, Thompson AJ, Kendall BE, Moseley IF, MacManus DG. McDonald WI, Miller DH. 1993. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43:2632-2637.
17. Kidd D, Thorpe JW, Kendall BE, Barker GJ, Miller DH, McDonald WI, Thompson AJ. 1996. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatr 60:15-19.
18. Lehrich JR. Arnason BGW, Hochberg FH. 1976. Demyelinative myelopathy in mice induced by the DA virus. J Neurol Sci 29:149-160.
19. Lipton HL. 1975. Theiler's virus infection in mice: an unusual biphasic disease leading to demyelination. Infect Immun 11:1147-1155.
20. Lipton HL, Dal Canto MC. 1976. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J Neurol Sci 30:201-207.
21. Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, Tofts PS, McDonald WI, Miller DH, Thompson AJ. 1996. Spinal cord atrophy and disability in multiple sclerosis. Brain 119:701-708.
22. Lycklama a Nijeholt GJ, van Walderveen MAA, Castelijns JA, va Waesberghe JHTM, Polman C. Scheltens P. Rosier PFWM, Jongen PJH, Barkhof F. 1998. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes, and symptoms. Brain 121:687-697.
23. Martin R, McFarland HF, McFarlin DE. 1992. Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153-187.
24. Matthews PM, De Stefane N, Narayanan S, Francis G, Wolinsky JS, Antel JP, Arnold DL. 1998. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol 18:327-336.
25. McGavern DB, Zoecklein L, Drescher KM, Rodriguez M. 1998. Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Exp Neurol 158:171-181.
26. Miller DJ, Rodriguez M. 1996. Spontaneous central nervous system remyelination in strain A mice after infection with the Daniel's (DA) strain of Theiler's virus. Acta Neurpathol 91:559-565.
27. Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M. 1994. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14:6230-6238.
28. 2 microglobulin-deficient mice following virus-induced demyelination. J Neurosci 15:8345-8352.
29. Narayanan S, Fu L, Pioro E, Stefano N, Collins DL, Francis GS, Antel JP, Matthews PM, Arnold DL. 1997. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 41:385-391.
30. Noble LJ, Wrathall JR. 1985. Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord. Exp Neurol 88:135-149.
31. Pullen LC, Miller SD, Dal Canto MC, Kim BS. 1993. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur J Immunol 23:2287-2293.
32. Raine CS, Cross AH. 1989. Axonal dystrophy as a consequence of long-term demyelination. Lab Invest 60:714-725.
33. Rivera-Quinones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M. 1998. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nature Med 4:187-193.
34. Rodriguez M, Lennon VA. 1990. Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 27:12-17.
35. Rodriguez M, Lindsley MD. 1992. Immunosuppression promotes central nervous system remyelination in chronic virus-induced demyelinating disease. Neurology 42:348-357.
36. Rodriguez M, Lennon VA. Benveniste EN, Merrill JE. 1987a. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol 46:84-95.
37. Rodriguez M, Oleszak E, Leihowitz J, 1987b. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol 7:325-365.
38. 2-microglobulin. J Immunol 151:266-276.
39. Rodriguez M, Miller DJ, Lennon VA. 1996. Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology 46:538-545.
40. Rosenberg LJ, Wrathall JR. 1997. Quantitative analysis of acute axonal pathology in experimental spinal cord contusion. J Neurotrauma 14:823-838.
41. Rosenberg LJ, Teng YD, Wrathall JR. 1999. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J Neurosci 19:464-475.
42. Stefano N, Matthews PM, Narayanan S, Francis G, Antel JP, Arnold DL. 1997. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology 49:1138-1141.
43. Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis G, Antel JP, Arnold DL. 1998. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 121:1469-1477.
44. Stevenson VL, Leary SM, Losseff NA, Parker GJM, Barker GJ, Husmani Y, Miller DH, Thompson AJ. 1998. Spinal cord atrophy and disability in MS. A longitudinal study. Neurology 51:234-238.
45. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. 1998. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.